STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[8-K] XOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

XOMA Royalty Corporation filed a Current Report announcing it issued a press release that reports the company's financial results for the fiscal quarter ended June 30, 2025. The filing states the full text of that press release is attached as Exhibit 99.1 and is incorporated by reference into the report.

The Form also notes that the information in the Form and the attached Exhibit is not to be deemed filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference in other filings except as expressly stated. The Form itself does not present financial figures; readers must consult Exhibit 99.1 for the results and highlights.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine 8-K attaching the Q2 2025 press release; no financial metrics are included within the Form itself.

The filing formally attaches a press release titled "XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements" as Exhibit 99.1 and includes an Inline XBRL cover page (Exhibit 104). Because the Form contains the press release by reference rather than embedding numeric disclosures in the body, investors must review Exhibit 99.1 to see revenues, earnings, or other performance metrics. The filing also clarifies the Exhibit is not deemed filed under Section 18, limiting certain incorporation liabilities.

TL;DR: Compliance-focused 8-K that documents disclosure of quarterly results via press release and clarifies legal filing status.

This Form 8-K performs a standard disclosure function by attaching a corporate press release and listing exhibits. It documents the company’s procedural step of incorporating a press release by reference and states that the material is not deemed "filed" under Section 18, which preserves specific disclosure liabilities. The filing does not introduce governance changes, leadership updates, or transaction details; it is a procedural notice directing stakeholders to Exhibit 99.1 for substantive financial content.

XOMA Royalty Corp false 0000791908 0000791908 2025-08-13 2025-08-13 0000791908 us-gaap:CommonStockMember 2025-08-13 2025-08-13 0000791908 xoma:M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember 2025-08-13 2025-08-13 0000791908 xoma:DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember 2025-08-13 2025-08-13
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 13, 2025

 

 

XOMA ROYALTY CORPORATION

(Exact Name of Registrant as Specified in Charter)

 

 

 

Nevada   001-39801   52-2154066
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification Number)

2200 Powell Street, Suite 310, Emeryville, California 94608

(Address of Principal Executive Offices) (Zip Code)

(510) 204-7200

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:

 

Trading

symbol(s):

 

Name of each exchange
on which registered:

Common Stock, $0.0075 par value   XOMA   The Nasdaq Global Market
8.625% Series A Cumulative Perpetual Preferred Stock, par value $0.05 per share   XOMAP   The Nasdaq Global Market
Depositary Shares (each representing 1/1000th interest in a share of 8.375% Series B Cumulative Perpetual Preferred Stock, par value $0.05 per share)   XOMAO   The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 2.02

Results of Operations and Financial Condition.

On August 13, 2025, XOMA Royalty Corporation issued a press release announcing its financial results for the fiscal quarter ended June 30, 2025. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Form 8-K and the Exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

 

Number    Description of Document
99.1    Press release entitled “XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements” dated August 13, 2025
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    XOMA ROYALTY CORPORATION
Date: August 13, 2025     By:  

/s/ Thomas Burns

      Thomas Burns
      Senior Vice President, Finance and Chief Financial Officer

FAQ

What did XOMA Royalty (XOMAP) disclose in this Form 8-K?

The company disclosed that it issued a press release reporting its financial results for the fiscal quarter ended June 30, 2025, and attached that press release as Exhibit 99.1 to the Form 8-K.

Where can I find the full Q2 2025 financial results for XOMA Royalty?

The full text of the results and highlights is contained in the press release attached as Exhibit 99.1; the Form directs readers to that Exhibit for the substantive figures.

Does this Form 8-K itself contain financial numbers or tables?

No. The Form states the press release is attached as Exhibit 99.1 and does not present the financial figures in the body of the Form; consult Exhibit 99.1 for the detailed results.

Is the attached press release considered 'filed' under Section 18 of the Exchange Act?

No. The Form explicitly states the information in the Form and Exhibit shall not be deemed 'filed' for purposes of Section 18 and is not incorporated by reference in other filings except as expressly set forth.

What securities and trading symbols are listed for XOMA Royalty in the filing?

The filing lists Common Stock (XOMA), 8.625% Series A Cumulative Perpetual Preferred Stock (XOMAP), and Depositary Shares representing Series B preferred (XOMAO), each traded on the Nasdaq Global Market.
XOMA Royalty Corporation

NASDAQ:XOMAP

XOMAP Rankings

XOMAP Latest News

XOMAP Latest SEC Filings

XOMAP Stock Data

984.00k
1.82%
Biotechnology
Pharmaceutical Preparations
Link
United States
EMERYVILLE